HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced encouraging results from in vivo animal studies completed at Rush University Medical Center under the direction of renowned researcher, Howard An, M.D.
